All Pharmacy Peptides
BPC-157 Injectable in its pharmacy container
Pharmacy Peptides · InjectableNew

BPC-157 Injectable, 15 mg

A licensed provider approves before anything ships.

Made by a 503A facility for your prescription. Compounded drugs are not FDA-approved and are not the same as brand-name medications.

$149.99/mo

Plus a 3% service fee and any state tax at checkout.

3-month minimum: cancel before month 3 and it's $35 for each month left. No fee after that.

Strength
10 mg · $139.9915 mg · $149.99

Your provider confirms the strength that fits.

How to buy

LegitScript certifiedUS-licensed providers503A facility

$179.49 a month with the 3% service fee and $25 shipping. Plus any state tax.

Quick facts

Form
Injectable vial
Size
15 mg
How you get it
A prescription by a licensed provider
Made by
Made by a 503A facility for your prescription.
Ingredients
One ingredient per product. Never blended.
Policy
One of six peptides in HHS's interim compounding policy

How this works

  • Prescribed for youA US-licensed provider reviews your history before anything is filled, and decides whether it's right for you.
  • Filled for your prescriptionMade by a 503A facility for your prescription. Shipped to you. Syringes and alcohol prep pads included.
  • LegitScript certifiedIndependently checked for safe, legal telehealth practice. See our certification
  • Not approved? You pay nothingIf the provider doesn't approve it, it's refunded in full automatically.

What “not FDA-approved” means: compounded medicines are made by a licensed pharmacy and filled for an individual prescription. The FDA doesn't review compounded medicines for safety, effectiveness or quality before they're dispensed, the way it reviews approved drugs. Your provider decides whether one is right for you.

  • 503A facility
  • Single ingredient
  • Prescription required
HHS policy on hhs.gov
Is this right for you?

It may fit if:

  • You want a licensed provider to review your history before anything is prescribed
  • You want one ingredient, made for your prescription. Made by a 503A facility for your prescription.
  • You want to know who made it and how to report a problem
  • You'd rather not buy something labeled “not for human use”
  • You're comfortable with an injection, with directions from your provider

A licensed provider decides whether it's right for you, after reviewing your intake.

Research

What the research says (and doesn't)

What researchers have studied, and what they have not shown. None of this is a claim about what this peptide does for you; your provider talks with you about what is and isn't known.

Studied

  1. Review article

    A 2025 systematic review covered 36 studies, 35 of them preclinical, in muscle, tendon, ligament and bone injury models, mostly in rats and rabbits.

    “In preclinical models, BPC-157 improved functional, structural, and biomechanical outcomes in muscle, tendon, ligament, and bony injuries.”

  2. Animal study

    FDA summarized rat studies on gastrointestinal and liver lesion models, and noted that dose-response relationships and molecular targets have not been established.

    “in rats, BPC-157-related substances could prevent colonic fistulas, hepatic lesions, and GI lesions induced by different challenges.”

  3. Small human study

    A retrospective chart study at one clinic reported 17 patients who received knee injections of BPC-157, alone or with TB4; 16 were asked about knee pain by phone afterwards. There was no control group.

    “A retrospective study was done at the Institute for Hormonal Balance in Orlando, Florida, USA.”

  4. Review article

    A 2026 systematic review found three human studies with 30 people in total (knee pain, interstitial cystitis and an intravenous safety pilot) and rated the certainty of evidence very low.

    “Overall certainty of evidence was rated very low due to serious risk of bias, indirectness and imprecision.”

  5. FDA review

    FDA found five small human studies, using rectal enema, knee injection, bladder instillation or intravenous dosing, and described them as short and exploratory with limited safety reporting.

    “No serious adverse events appear to have been reported with these studies.”

Not shown

  • No large randomized human trial has been completed. Two randomized trials (a hamstring strain and a rotator cuff study) are registered with no results yet, and a 2015 Phase 1 oral-tablet trial has posted none.
  • FDA found no human studies by the subcutaneous, oral, nasal or transdermal routes, and no human pharmacokinetic data.
  • FDA raised immunogenicity, impurity and aggregation concerns for injected or nasal BPC-157 and described it as not well-characterized.
  • FAERS reports included injection-site reaction, shortness of breath and hyperpigmentation; FDA said it is unclear whether BPC-157 caused them.

BPC-157 is not FDA-approved. FDA stated that no product containing it is approved in any country. In briefing documents for its July 23–24, 2026 Pharmacy Compounding Advisory Committee meeting, FDA proposed not adding BPC-157 to the 503A bulks list; the committee's votes and any final FDA decision were not found. HHS's interim policy describes the conditions under which HHS does not intend to act against a 503A pharmacy that compounds it for a patient's own prescription.

FDA PCAC briefing document, BPC-157 (July 2026) HHS interim peptide policy (Appendix B)

If you compete in tested sport: USADA lists BPC-157 as prohibited (WADA class S0, non-approved substances). Source

Sources: FDA, NIH/PubMed, ClinicalTrials.gov, USADA, HHS

What you should know

What it is

BPC-157 is a 15-amino-acid peptide. It is one of the six peptides in an interim HHS policy for compounding pharmacies. Compounded drugs are not FDA-approved and are not the same as brand-name medications. Nothing is made or shipped until a licensed provider approves it for you. If a provider says it's not right for you, you pay nothing.

Who it's for

You want a peptide prescribed by a licensed provider, not a research-use vial. You want one ingredient, made for your prescription. You want a person to ask between visits.

What comes in the box

Your BPC-157 Injectable, 15 mg, the syringes and alcohol prep pads you need for each injection, and the pharmacy insert, shipped cold-packed.

Can I get BPC-157 with a prescription?

Yes, by prescription. BPC-157 is one of the six peptides in HHS's interim policy (October 2026). A licensed provider decides whether it's right for you; if it is, it's made for your prescription by a 503A facility and shipped to you. Compounded drugs are not FDA-approved and are not the same as brand-name medications.

Do I need a membership for BPC-157?

No. You can order BPC-157 on its own: a short intake, a licensed provider's approval, and your prescription made and shipped. A membership adds four lab panels and four provider visits a year and a wellness consultant between visits.

How it's made

Made by a 503A facility for your prescription. One ingredient per product. Never blended. It is labeled with your name and your prescription.

Who sets the dose?

Your provider sets the dose.

Is it FDA-approved?

No. Compounded drugs are not FDA-approved and are not the same as brand-name medications. The HHS policy that covers it is not FDA approval, and HHS can revisit it.

Side effects and reporting

Tell your care team about anything you notice. Anyone can also report a side effect to the FDA through MedWatch.

Build your plan

Often paired with BPC-157 Injectable, 15 mg.

Labs + Provider + Person = Your plan

Membership from $89.92/mo

4 Labcorp lab panels, 4 provider visits and a wellness consultant every year, on the annual plan. $149.99 month to month.

Start membership